Luigi Buonaguro
Luigi Buonaguro
National Cancer Institute Pascale, Naples IT
Email verificata su
Citata da
Citata da
Release, uptake, and effects of extracellular human immunodeficiency virus type 1 Tat protein on cell growth and viral transactivation
B Ensoli, L Buonaguro, G Barillari, V Fiorelli, R Gendelman, RA Morgan, ...
Journal of virology 67 (1), 277-287, 1993
Human immunodeficiency virus type 1 subtype distribution in the worldwide epidemic: pathogenetic and therapeutic implications
L Buonaguro, ML Tornesello, FM Buonaguro
Journal of virology 81 (19), 10209-10219, 2007
HIV-1 Tat protein exits from cells via a leaderless secretory pathway and binds to extracellular matrix-associated heparan sulfate proteoglycans through its basic region
HC Chang, F Samaniego, BC Nair, L Buonaguro, B Ensoli
Aids 11 (12), 1421-1431, 1997
Effects of the human immunodeficiency virus type 1 Tat protein on the expression of inflammatory cytokines
L Buonaguro, G Barillari, HK Chang, CA Bohan, V Kao, R Morgan, ...
Journal of virology 66 (12), 7159-7167, 1992
Global and regional molecular epidemiology of HIV-1, 1990–2015: a systematic review, global survey, and trend analysis
J Hemelaar, R Elangovan, J Yun, L Dickson-Tetteh, I Fleminger, S Kirtley, ...
The Lancet infectious diseases 19 (2), 143-155, 2019
Translating tumor antigens into cancer vaccines
L Buonaguro, A Petrizzo, ML Tornesello, FM Buonaguro
Clinical and Vaccine Immunology 18 (1), 23-34, 2011
Antimicrobial peptides as anticancer agents: functional properties and biological activities
AL Tornesello, A Borrelli, L Buonaguro, FM Buonaguro, ML Tornesello
Molecules 25 (12), 2850, 2020
Effects of cytokines from activated immune cells on vascular cell growth and HIV-1 gene expression. Implications for AIDS-Kaposi's sarcoma pathogenesis.
G Barillari, L Buonaguro, V Fiorelli, J Hoffman, F Michaels, RC Gallo, ...
Journal of immunology (Baltimore, Md.: 1950) 149 (11), 3727-3734, 1992
Update on head and neck cancer: current knowledge on epidemiology, risk factors, molecular features and novel therapies
F Pezzuto, L Buonaguro, F Caponigro, F Ionna, N Starita, C Annunziata, ...
Oncology 89 (3), 125-136, 2015
Mutations in TP53, CTNNB1 and PIK3CA genes in hepatocellular carcinoma associated with hepatitis B and hepatitis C virus infections
ML Tornesello, L Buonaguro, F Tatangelo, G Botti, F Izzo, FM Buonaguro
Genomics 102 (2), 74-83, 2013
Antigen-specific vaccines for cancer treatment
M Tagliamonte, A Petrizzo, ML Tornesello, FM Buonaguro, L Buonaguro
Human vaccines & immunotherapeutics 10 (11), 3332-3346, 2014
The role of microRNAs, long non-coding RNAs, and circular RNAs in cervical cancer
ML Tornesello, R Faraonio, L Buonaguro, C Annunziata, N Starita, ...
Frontiers in oncology 10, 150, 2020
Viral and cellular biomarkers in the diagnosis of cervical intraepithelial neoplasia and cancer
ML Tornesello, L Buonaguro, P Giorgi-Rossi, FM Buonaguro
BioMed research international 2013, 2013
The human immunodeficiency virus type 1 Tat protein transactivates tumor necrosis factor beta gene expression through a TAR-like structure
L Buonaguro, FM Buonaguro, G Giraldo, B Ensoli
Journal of virology 68 (4), 2677-2682, 1994
Baculovirus-derived human immunodeficiency virus type 1 virus-like particles activate dendritic cells and induce ex vivo T-cell responses
L Buonaguro, ML Tornesello, M Tagliamonte, RC Gallo, LX Wang, ...
Journal of virology 80 (18), 9134-9143, 2006
High-level expression of the HIV-1 Pr55gag polyprotein in transgenic tobacco chloroplasts
N Scotti, F Alagna, E Ferraiolo, G Formisano, L Sannino, L Buonaguro, ...
Planta 229, 1109-1122, 2009
Analysis of Tat transactivation of human immunodeficiency virus transcription in vitro
CA Bohan, F Kashanchi, B Ensoli, L Buonaguro, KA Boris-Lawrie, ...
Gene expression 2 (4), 391, 1992
Tumor genotype and immune microenvironment in POLE-ultramutated and MSI-hypermutated endometrial cancers: new candidates for checkpoint blockade immunotherapy?
P Gargiulo, C Della Pepa, S Berardi, D Califano, S Scala, L Buonaguro, ...
Cancer treatment reviews 48, 61-68, 2016
Human papillomavirus (HPV) genotypes and HPV16 variants and risk of adenocarcinoma and squamous cell carcinoma of the cervix
ML Tornesello, S Losito, G Benincasa, F Fulciniti, G Botti, S Greggi, ...
Gynecologic oncology 121 (1), 32-42, 2011
Developments in virus-like particle-based vaccines for infectious diseases and cancer
L Buonaguro, M Tagliamonte, ML Tornesello, FM Buonaguro
Expert review of vaccines 10 (11), 1569-1583, 2011
Il sistema al momento non pu eseguire l'operazione. Riprova pi tardi.
Articoli 1–20